Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DR. AGARWAL'S HEALTH CARE LTD.

NSE : AGARWALEYEBSE : 544350ISIN CODE : INE943P01029Industry : Hospital & Healthcare ServicesHouse : Private

BSE422.30-6.55 (-1.53 %)

PREV CLOSE ( ) 428.85

OPEN PRICE ( ) 433.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 31209

TODAY'S LOW / HIGH ( )418.55 434.50

52 WK LOW / HIGH ( )370.1 463.85

NSE422.95-5.6 (-1.31 %)

PREV CLOSE( ) 428.55

OPEN PRICE ( ) 434.65

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 422.95 (128)

VOLUME 308000

TODAY'S LOW / HIGH( ) 420.10 434.65

52 WK LOW / HIGH ( )365.7 464

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-04 2010

Management Info

Amar Agarwal - Chairman - Managing Director

Registered Office

Address 1st Floor, Buhari Towers, No.4,Moores Road, Off Greams Road,Near Asan Memorial School,
Chennai,
Tamil Nadu-600006

Phone 044-43787777

Email secretarial@dragarwal.com

Website www.dragarwals.co.in

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

10Mar Dr. Agarwals Health Care informs about
Pursuant to Regulation 30 read with Para B of Part A of Schedule III of..

06Mar Dr. Agarwal's Health Care’s arm inaugu
Dr. Agarwal's Health Care’s subsidiary -- Dr Agarwal's Eye Hospital has..

06Mar Dr. Agarwal’s Health Care informs abou
Pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulati..

24Feb Dr. Agarwal’s Health Care informs abou
Pursuant to Regulation 30 read with Para B of Part A of Schedule III of..

17Feb Dr. Agarwal’s Health Care informs abou
Pursuant to Regulation 30 of SEBI (LODR) Regulations, Dr. Agarwal’s Heal..

Financials

Rs. in Millions

	QTR Dec 24	ANNUAL
Net Profit	76.2000000000001
Gross Profit	121
Operating Profit	751.9
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Jupiter Life Line (BSE) 1550.10 (3.15%)	M.Cap ( in Cr)10163.39
Thyrocare Tech. (BSE) 699.85 (3.87%)	M.Cap ( in Cr)3708.75
Krishna Inst.Medi (BSE) 569.95 (3.66%)	M.Cap ( in Cr)22805.92
Suraksha Diagnostic (BSE) 278.40 (7.72%)	M.Cap ( in Cr)1449.93
RainbowChildrenS Med (BSE) 1257.90 (1.14%)	M.Cap ( in Cr)12774.18

Shareholding Pattern

	NON-INSTITUTION	62.7%
	PROMOTERS	37.3%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

DR. AGARWAL'S HEALTH CARE LTD.